Malkin CJ - Search Results

1

The effect of testosterone on insulin sensitivity in men with heart failure.

Malkin CJ, Jones TH, Channer KS. Malkin CJ, et al. Eur J Heart Fail. 2007 Jan;9(1):44-50. doi: 10.1016/j.ejheart.2006.04.006. Epub 2006 Jul 7. Eur J Heart Fail. 2007. PMID: 16828341

2

Testosterone for secondary prevention in men with ischaemic heart disease?

Malkin CJ, Pugh PJ, Jones TH, Channer KS. Malkin CJ, et al. QJM. 2003 Jul;96(7):521-9. doi: 10.1093/qjmed/hcg086. QJM. 2003. PMID: 12881595 Review. No abstract available.

3

Testosterone as a protective factor against atherosclerosis--immunomodulation and influence upon plaque development and stability.

Malkin CJ, Pugh PJ, Jones RD, Jones TH, Channer KS. Malkin CJ, et al. J Endocrinol. 2003 Sep;178(3):373-80. doi: 10.1677/joe.0.1780373. J Endocrinol. 2003. PMID: 12967330 Review.

4

Effect of testosterone therapy on QT dispersion in men with heart failure.

Malkin CJ, Morris PD, Pugh PJ, English KM, Channer KS. Malkin CJ, et al. Am J Cardiol. 2003 Nov 15;92(10):1241-3. doi: 10.1016/j.amjcard.2003.07.044. Am J Cardiol. 2003. PMID: 14609611 Clinical Trial.

5

The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men.

Malkin CJ, Pugh PJ, Jones RD, Kapoor D, Channer KS, Jones TH. Malkin CJ, et al. J Clin Endocrinol Metab. 2004 Jul;89(7):3313-8. doi: 10.1210/jc.2003-031069. J Clin Endocrinol Metab. 2004. PMID: 15240608 Clinical Trial.

6

Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life.

Malkin CJ, Pugh PJ, Morris PD, Kerry KE, Jones RD, Jones TH, Channer KS. Malkin CJ, et al. Heart. 2004 Aug;90(8):871-6. doi: 10.1136/hrt.2003.021121. Heart. 2004. PMID: 15253956 Free PMC article. Clinical Trial.

7

A mathematical comparison of techniques to predict biologically available testosterone in a cohort of 1072 men.

Morris PD, Malkin CJ, Channer KS, Jones TH. Morris PD, et al. Among authors: malkin cj. Eur J Endocrinol. 2004 Aug;151(2):241-9. doi: 10.1530/eje.0.1510241. Eur J Endocrinol. 2004. PMID: 15296480

8

Testosterone does not adversely affect fibrinogen or tissue plasminogen activator (tPA) and plasminogen activator inhibitor-1 (PAI-1) levels in 46 men with chronic stable angina.

Smith AM, English KM, Malkin CJ, Jones RD, Jones TH, Channer KS. Smith AM, et al. Among authors: malkin cj. Eur J Endocrinol. 2005 Feb;152(2):285-91. doi: 10.1530/eje.1.01848. Eur J Endocrinol. 2005. PMID: 15745938 Clinical Trial.

9

Life-saving or life-prolonging? Interpreting trial data and survival curves for patients with congestive heart failure.

Malkin CJ, Channer KS. Malkin CJ, et al. Eur J Heart Fail. 2005 Mar 2;7(2):143-8. doi: 10.1016/j.ejheart.2004.07.004. Eur J Heart Fail. 2005. PMID: 15762009 Review.

10

Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial.

Malkin CJ, Pugh PJ, West JN, van Beek EJ, Jones TH, Channer KS. Malkin CJ, et al. Eur Heart J. 2006 Jan;27(1):57-64. doi: 10.1093/eurheartj/ehi443. Epub 2005 Aug 10. Eur Heart J. 2006. PMID: 16093267 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results